SCHEMBL18407490

SCHEMBL18407490

Cc1ccc(C[C@@H](O)C(=O)OCc2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
LTA4H P09960 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
LAP3 P28838 1/20 0.50
TACR1 P25103 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
MAPT P10636 1/20 0.48
ATM Q13315 1/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.47
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
CTSL P07711 1/20 0.46
CTSK P43235 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
MAPK1 P28482 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22502779 1.00 ALDH1A1 (0.50) ALDH1A1LTA4HNPC1RAB9ALAP3
SCHEMBL4219709 0.90 ALDH1A1 (0.55) ALDH1A1LTA4HLAP3TACR1L3MBTL1
SCHEMBL262278 0.90 ALDH1A1 (0.55) ALDH1A1LTA4HLAP3TACR1L3MBTL1
SCHEMBL7046944 0.90 ALDH1A1 (0.55) ALDH1A1LTA4HLAP3TACR1L3MBTL1
SCHEMBL19088598 0.87 LMNA (0.56) ALDH1A1LTA4HLAP3L3MBTL1LMNA
SCHEMBL23279551 0.86 MAPT (0.51) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL27410647 0.85 LDHA (0.55) ALDH1A1LTA4HNPC1RAB9ALAP3
SCHEMBL18256456 0.84 LTA4H (0.50) ALDH1A1LTA4HNPC1RAB9ALAP3
SCHEMBL8953583 0.84 LTA4H (0.53) ALDH1A1LTA4HNPC1RAB9ALAP3
SCHEMBL23279460 0.84 PPARG (0.52) ALDH1A1LTA4HLAP3L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018048-B2 Anthelmintic depsipeptide compounds Boehringer Ingelheim Animal Health USA Inc. (US) 2024-06-25 US disclosed
US-20170233438-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS MERIAL INC. (US) 2017-08-17 US disclosed
US-20170022253-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS MERIAL INC. (US) 2017-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12018048-B2 Anthelmintic depsipeptide compounds VIP, DNPEP, DPEP1 ALDH1A1 2924/4885LTA4H 360/4885NPC1 2239/4885
US-20170022253-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS VIP, PREP, DNPEP ALDH1A1 3037/4885LTA4H 327/4885NPC1 2188/4885
US-20170233438-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS VIP, PREP, DNPEP ALDH1A1 2890/4885LTA4H 279/4885NPC1 1789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.